Journals / Ulusal Cerrahi Dergisi / 2014 / Cilt: 30 - Sayı: 2

Evaluation of factors affecting mortality in Fournier's Gangrene: Retrospective clinical study of sixteen cases

Fournier Gangreni'nde mortaliteyi etkileyen faktörlerin değerlendirilmesi: On altı olguluk retrospektif klinik çalışma

Pages
85–89
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Early diagnosis and determination of the severity of the disease, aggressive surgical debridement and appropriate antimicrobial therapy may improve prognosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Fournier's gangrene is a progressive, necrotizing fasciitis due to synergistic infection of the perineum and external genitalia that is associated with high mortality and morbidity.
📊
Key Findings & Data:The purpose of this study is to review the diagnostic and treatment methods that effect mortality in Fournier's gangrene.Material and Methods: Sixteen patients who were diagnosed and treated at our clinic between 2011 and 2013 due to Fournier's gangrene were retrospectively analyzed.
💡
Conclusion & Impact:Early diagnosis and determination of the severity of the disease, aggressive surgical debridement and appropriate antimicrobial therapy may improve prognosis.
🔬Design:Review & Systematic Survey
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Fournier's gangrene is a progressive, necrotizing fasciitis due to synergistic infection of the perineum and external genitalia that is associated with high mortality and morbidity. The purpose of this study is to review the diagnostic and treatment methods that effect mortality in Fournier's gangrene.Material and Methods: Sixteen patients who were diagnosed and treated at our clinic between 2011 and 2013 due to Fournier's gangrene were retrospectively analyzed. The surviving and non-surviving patient groups were compared in terms of age, sex, onset time of symptoms, isolated microorganisms, concomitant diseases, Fournier's gangrene severity index (FGSI), and length of hospital stay.Results: Ten of our cases (62.5%) were male and six (37.5%) were female, with a mean age of 61.2±12.3 years. The mortality rate was 18.8% (3 cases). The mean duration of symptoms before admission was 4.31±1.81 days. This period was 6.67±1.52 days in patients who succumbed to death, and 3.77±1.42 days in patients who survived (p=0.007). Ten cases (62.5%) had concomitant diabetes mellitus. The most common organism isolated in wound cultures was Escherichia coli (68.7%), and Acinetobacter baumannii, Proteus mirabilis, methicillin-resistant Staphylococcus aureus and Enterococcus spp. in the remaining patients. The mean FGSI of surviving patients was 3.84±1.77, and 7.66±0.57 in fatal cases (p=0.003). The mean length of hospital stay was 25.5 days and duration of hospitalization was significantly longer in survivors (p<0.05).Conclusion: The delay in diagnosis and higher FGSI may be responsible for worsening of prognosis and mortality in Fournier's gangrene. Early diagnosis and determination of the severity of the disease, aggressive surgical debridement and appropriate antimicrobial therapy may improve prognosis.

Özet

Amaç: Fournier gangreni, yüksek mortalite ve morbidite ile seyreden, hızlı ilerleyen, perine ve eksternal genital organların sinerjistik enfeksiyonuna bağlı nekrotizan fasiitisidir. Bu çalışmanın amacı, Fournier gangreninde mortaliteye etki eden teşhis ve tedavi yöntemlerinin gözden geçirilmesidir.Gereç ve Yöntemler: Bu çalışmamızda, kliniğimizde 2011-2013 yılları arasında Fournier gangreni nedeni ile teşhis ve tedavi uygulanan 16 olgu retrospektif olarak incelenmiştir. Yaşayan ve mortal seyreden hasta grupları yaş, cins, semptomların başlangıç süresi, etken mikroorganizmalar, eşlik eden hastalıklar, Fournier gangreni şiddet indeksi (FGSI), hastanede yatış süresi açısından karşılaştırıldı.Bulgular: Olgularımızın 10'u (%62,5) erkek, 6'sı (%37,5) kadın olup, yaş ortalaması 61,2±12,3 idi. Mortalite 3 olguda (%18,8) saptandı. Olguların başvuru anındaki yakınma süreleri ortalama 4,31±1,81 gün olarak saptandı. Mortal seyreden olgularda bu süre 6,67±1,52 gün, yaşayan olgularda 3,77±1,42 gün idi (p=0,007). Olguların 10'unda (%62,5) eşlik eden diabetes mellitus saptandı. Yara örneklerinden yapılan kültür sonuçlarında en sık olarak Escherichia coli (%68,7), kalan hastalarda Acinetobacter baumannii, Proteus mirabilis, methicillin-dirençli Staphylococcus aureus ve Enterococcus spp. üremiştir. Yaşayan olguların FGSI ortalaması 3,84±1,77, mortal seyreden olguların 7,66±0,57 idi (p=0,003). Hastanede yatış süresi ortalama 25,5 gün olup, yatış süresi sağ kalanlarda anlamlı derecede uzun idi (p<0,05).Sonuç: Fournier gangreninde teşhiste geç kalınması ve FGSI yüksekliği prognozun kötüleşmesi ve mortaliteden sorumlu olabilmektedir. Erken tanı ve hastalığın şiddetinin tayini; uygun antibiyoterapi ile birlikte agresif cerrahi debridman hastalığın prognozunu olumlu yönde etkileyebilmektedir.

🔖

Cite This Article

OYMACI, E., COŞKUN, A., YAKAN, S., ERKAN, N., UÇAR, A. D., YILDIRIM, M. (2014). Evaluation of factors affecting mortality in Fournier's Gangrene: Retrospective clinical study of sixteen cases. Ulusal Cerrahi Dergisi, Cilt: 30 - Sayı: 2, 85–89. https://ajindex.com/articles/325430

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Norton KS, Johnson LW, Perry T, Perry KH, Sehon JK, Zibari GB. Management of Fournier's gangrene: an eleven year retrospective analysis of early recognition, diagnosis, and treatment. Am Surg 2002; 68: 709-713
  2. Atakan IH, Kaplan M, Kaya E, Aktoz T, Inci O. A life-threatening infection: Fournier's gangrene. Int Urol Nephrol 2002; 34: 387-392. [CrossRef] 3. Geraci G, Pisello F, Lupo F, Cajozzo M, Sciume C, Modica G. Fournier's gangrene: case report and review of recent literature. Ann Ital Chir 2004; 75: 97-106
  3. Unal B, Kocer B, Ozel E, Bozkurt B, Yildirim O, Altun B, et al. Fournier gangrene. Approaches to diagnosis and treatment. Saudi Med J 2006; 27: 1038-1043
  4. Jeong HJ, Park SC, Seo IY, Rim JS. Prognostic factors in Fournier gangrene. Int J Urol 2005; 12: 1041-1044. [CrossRef] 6. Korkut M, Içöz G, Dayangaç M, Akgün E, Yeniay L, Erdoğan O, et al. Outcome analysis in patients with Fournier's gangrene: report of 45 cases. Dis Colon Rectum 2003; 46: 649-652. [CrossRef] 7. Canbaz H, Çağlıkülekçi M, Altun U, Dirlik M, Türkmenoğlu Ö, Taş- delen B, ve ark. Fournier gangreni: 18 olgudaki prognoza etki eden risk faktörlerinin ve tedavi maliyetinin değerlendirilmesi. Ulus Travma Acil Cerrahi Derg 2010; 16: 71-76
  5. Laor E, Palmer LS, Tolia BM, Reid RE, Winter HI. Outcome prediction in patients with Fournier's gangrene. J Urol 1995; 154: 89-92. [CrossRef] 9. Kara E, Müezzinoğlu T, Temeltas G, Dinçer L, Kaya Y, Sakarya A, et al. Evaluation of risk factors and severity of a life threatening surgical emergency: Fournier's gangrene (a report of 15 cases). Acta Chirc Belg 2009; 109: 191-197
  6. Sroczynski M, Sebastian M, Rudnicki J, Sebastian A, Agrawal AK. A complex approach to the treatment of Fournier's gangrene. Adv Clin Exp Med 2013; 22: 131-135
  7. Assenza M, Cozza V, Sacco E, Clementi I, Tarantino B, Passafiume F, et al. VAC (Vacuum Assisted Closure) treatment in Fournier's gangrene: personal experience and literature review. Clin Ter 2011; 162: 1-5
  8. Taviloglu K, Cabioglu N, Cagatay A, Yanar H, Ertekin C, Baspinar I, et al. Idiopathic necrotizing fasciitis: risk factors and strategies for management. Am Surg 2005; 71: 315-320
  9. Pawlowski W, Wronski M, Krasnodebski IW. Fournier's gangrene. Pol Merkur Lekarski 2004; 17: 85-87.